Diagnosing
Down-the-Drain Disposal of Unused Pharmaceuticals
at a River Catchment Level: Unrecognized Sources of Environmental
Contamination That Require Nontechnological Solutions
posted on 2021-08-23, 15:04authored byBarbara Kasprzyk-Hordern, Kathryn Proctor, Kishore Jagadeesan, Scott Watkins, Richard Standerwick, Ruth Barden, Julie Barnett
Down-the-drain
disposal of pharmaceuticals remains an overlooked
and unrecognized source of environmental contamination that requires
nontechnological “at-source” solutions. Monitoring of
31 pharmaceuticals over 7 days in five wastewater treatment plants
(WWTPs) serving five cities in South-West UK revealed down-the-drain
codisposal of six pharmaceuticals to three WWTPs (carbamazepine and
propranolol in city A, sildenafil in city B, and diltiazem, capecitabine,
and sertraline in city D), with a one-off record codisposal of estimated
253 pills = 40 g of carbamazepine and estimated 96 pills = 4 g of
propranolol in city A accounting for their 10- and 3-fold respective
increases in wastewater daily loads. Direct disposal of pharmaceuticals
was found to affect the efficiency of wastewater treatment with much
higher pharmaceutical removal (decrease in daily load) during “down-the-drain
disposal” days. This is due to lack of conjugated glucuronide
metabolites that are cleaved during “consumption-only”
days, with the release of a parent pharmaceutical counterbalancing
its removal. Higher removal of pharmaceuticals during down-the-drain
disposal days reduced pharmaceutical loads reaching receiving environment,
albeit with significant levels remaining. The estimated daily loads
in receiving water downstream from a discharge point accounted for
13.8 ± 3.4 and 2.1 ± 0.2 g day–1 of carbamazepine
and propranolol, respectively, during consumption-only days and peaked
at 20.9 g day–1 (carbamazepine) and 4.6 g day–1 (propranolol) during down-the-drain disposal days.
Actions are needed to reduce down-the-drain disposal of pharmaceuticals.
Our recent work indicated that down-the-drain disposal of pharmaceuticals
doubled since the last study in 2005, which may be due to the lack
of information and messaging that informs people to dispose of unused
medicines at pharmacies. Media campaigns that inform the public of
how to safely dispose of medicines are key to improving rates of return
and reducing pharmaceutical waste in the environment. The environment
is a key motivator for returning unused medicines to a pharmacy and
so messaging should highlight environmental risks associated with
improper disposal.